Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2003
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065981A2 Therapeutic use for lp229, in particular for wound healing
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2003027232A3 Method for producing biologically active products
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003009813A3 Methods of treating neuropilin-mediated diseases
08/14/2003WO2003001984A3 Method and apparatus for the photomodulation of living cells
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002096374A3 Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
08/14/2003WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003US20030153755 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
08/14/2003US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/14/2003US20030153628 Aldose reductase inhibitors and pharmaceutical compositions
08/14/2003US20030153627 Compounds for blocking androgen receptors
08/14/2003US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors
08/14/2003US20030153605 Enzyme inhibitors of nitric oxide synthase
08/14/2003US20030153602 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153578 CCR-3 receptor antagonists (I)
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153073 Expansion of T cells in vitro and expanded T cell populations
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152664 Microbiocides fatty acid mixed with feed
08/14/2003US20030152602 Topical applying; tissue penetration; bioavailability
08/14/2003US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses
08/14/2003US20030152596 Mixture of elastase inhibitor and fungicide or bactericide; antiinflammatory agent
08/14/2003US20030152594 Immunology response intensifiers; administering a bacterial lysate
08/14/2003US20030152536 Cosmetic preparations containing waltheria indica extracts
08/14/2003US20030152531 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
08/14/2003US20030152526 Bovine milk growth factor
08/14/2003DE10201747C1 Glas-Keramik-Komposit, Verfahren zu seiner Herstellung und Verwendungen Glass-ceramic composite, method for its preparation and uses
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2476281A1 Pyrimidine compounds
08/14/2003CA2476214A1 Proliferated cell lines and uses thereof
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475385A1 Hair growth promoting agent, percutaneously applied preparation, and hair growth promoting method
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475349A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475036A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2473143A1 Compositions containing oat straw and willowherb extract
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/14/2003CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins
08/13/2003EP1334983A2 Inhibitory, monoclonal antibody against the protease which activates clotting factor VII
08/13/2003EP1334731A1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
08/13/2003EP1334714A1 Use of ascorbic acid to stergthen the dermal-epidermal junction
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334124A2 Diastereomeric peptides and pharmaceutical compositions comprising them
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333805A2 Cosmetic method of treating skin
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1220656B1 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase
08/13/2003EP1152768B1 Treatment of chronic viral infections with m. vaccae
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0914096B1 Microparticles and their use in wound therapy
1 ... 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 ... 1065